Abpro Bio Co., Ltd. (KOSDAQ:195990)

Abpro Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	57,507	128,110	155,155	115,496	244,023	461,443
Market Cap Growth	-54.09%	-17.43%	34.34%	-52.67%	-47.12%	224.69%
Enterprise Value	66,946	112,040	146,682	101,187	216,105	466,966
Last Close Price	202.00	450.00	545.00	422.00	965.00	1835.00
Forward PE	-	4.78	4.78	4.78	4.78	4.78
PS Ratio	1.59	4.05	6.11	5.22	7.41	12.89
PB Ratio	0.95	1.19	1.27	0.82	1.77	3.34
P/TBV Ratio	1.31	1.41	1.40	0.84	1.82	3.33
P/FCF Ratio	-	-	-	-	-	185.32
P/OCF Ratio	-	-	-	-	-	167.15
EV/Sales Ratio	1.85	3.54	5.78	4.58	6.57	13.05
EV/EBITDA Ratio	-	-	-	-	-	87.17
EV/FCF Ratio	-3.06	-	-	-	-	187.54
Debt / Equity Ratio	0.26	0.20	0.10	0.08	0.16	0.08
Debt / EBITDA Ratio	-	-	-	-	-	2.13
Debt / FCF Ratio	-	-	-	-	-	4.58
Asset Turnover	0.30	0.22	0.17	0.14	0.20	0.19
Inventory Turnover	2.57	2.07	1.38	1.21	2.08	2.04
Quick Ratio	1.36	1.55	1.39	1.59	1.97	2.40
Current Ratio	3.07	2.33	2.50	2.86	2.75	3.90
Return on Equity (ROE)	-73.29%	-13.57%	-19.61%	-5.87%	-7.06%	-34.78%
Return on Assets (ROA)	-3.81%	-2.89%	-4.26%	-4.31%	-2.00%	-0.64%
Return on Invested Capital (ROIC)	-10.38%	-5.88%	-8.36%	-9.56%	-4.77%	-1.43%
Return on Capital Employed (ROCE)	-10.10%	-5.40%	-8.20%	-8.00%	-3.90%	-1.30%
Earnings Yield	-121.77%	-12.20%	-16.59%	-7.05%	-4.11%	-12.78%
FCF Yield	-38.08%	-17.84%	-3.87%	-10.90%	-1.13%	0.54%
Buyback Yield / Dilution	-0.03%	-4.78%	-3.72%	0.50%	-25.82%	-64.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.